Dr Manish (Mani) Mittal is a London-based hair transplant surgeon at Mittal Hair Clinic who performs FUE and is often discussed as an emerging UK option alongside names like Ball and Reddy.123 Feedback splits. Some describe him as a rising doctor with very natural-looking work and good hairline design, while others highlight a limited track record and mixed outcomes.12456 He is frequently described as personally involved, detail-oriented, and conservative in planning, though at least one patient reports a failed surgery and difficulty obtaining follow-up support.25

Based on our research, the signal on Dr Mittal is mixed. We have read multiple detailed positive case reports with natural hairlines, good density, and attentive aftercare, but we also saw a serious report of near-complete failure and poor post op support.2657 The positives include thorough doctor-led consultations, conservative planning, clear expectation setting, and a surgery model where he handles anaesthesia, extractions, and incisions while technicians implant.768 Several patients and observers frame him as a rising UK surgeon whose work reads as natural and versatile, with both conservative and more aggressive hairlines documented.1968 The risk side is not trivial. We have seen a case with almost no growth, very sparse coverage, and a markedly asymmetric hairline, along with frustration that follow-up was delayed and not meaningfully handled.2 We have also come across criticism that some of his hairlines look wonky or asymmetric, and that the failure case reinforces that concern.2 Community debate around him can be heated, including accusations that some accounts are defending him too aggressively, which makes the positive noise harder to weigh.2 Our read is that Mittal is not a low-risk, long-proven choice. The results range from excellent to very poor, and the downside risk of a bad aesthetic outcome with limited remediation support is real.

From what we have seen, patients consistently report FUE cases, typically 1,000 to roughly 2,500+ grafts, sometimes partial shave or no shave for smaller sessions.110961112 A detailed account describes a standard workflow: head shave, local anaesthetic by Mittal, extractions by him, technicians prepare grafts, Mittal makes all recipient incisions, and technicians implant while the patient is awake.7 Another patient confirms a proper in-person medical consultation before he agrees to operate, including candidacy and realistic expectations.6 He is often conservative in hairline design, aiming for mature or age-appropriate lines, though there are also more aggressive hairlines on request.9812 We have seen him ask patients to be on finasteride before surgery and delay operating to allow medication time to work, which reads as medically cautious.4 Surgery days commonly run from early morning to late afternoon, and at least one case reports he added about 100 grafts at the end to refine the result at no extra charge.7 The clinic is described as central London near King’s Cross/St Pancras, and easy to reach. A liaison named Russ often handles initial communications and logistics, while clinical decisions sit with Mittal.6

Results are described as natural by multiple patients, with hairlines that match prior patterns and are not obvious to casual observers at early and mid-term stages.961213 A 2,300-graft case at six months was described as absolutely delighted with how unnoticeable the work was to those who did not know.13 A 2,340-graft partial-shave at 7 to 8 months was praised for tidy execution and a conservative but impactful restoration.128 We have also read specific praise for density, clean spacing, and flexibility across conservative and more modern hairlines, though this is community enthusiasm rather than systematic data.918 The outlier is severe. One patient reports almost no growth, very sparse coverage, and one half of the hairline failing to grow, leaving a highly uneven result.2 A separate commenter has criticised what they see as a pattern of asymmetrical hairlines in some of his work and points to that failure as reinforcement.2 We have not seen donor depletion or scarring complaints in these excerpts; donor photos are mentioned but without formal density analysis.1415 Outcomes on forums range from delighted to a serious failure, which means reliability looks variable.

Consultations are often described as positive. Patients report meeting Mittal directly, in person or by video, with time spent on non-surgical options, hairline design, and realistic expectations. The process felt like a medical consult rather than a sales pitch.7616 One patient contrasted this with a Harley Street provider where they met only a salesperson, which pushed them toward Mittal.7 Surgery days are usually reported as smooth and well organised, with a friendly team, conversation during the procedure, and clear aftercare instructions on saline spraying and staged washing.76 At least one patient reports multiple post-op check-ins from Mittal and describes aftercare as great.13 Another says both Mittal and Russ were responsive to questions, though the recovery felt challenging.6 Local travel is straightforward for London patients.9 The difficult counterpoint is a patient with a reported failed transplant who describes poor follow-up: a delayed in-person review by two hours on the day, then evasive behaviour and no proper meeting, leaving them feeling abandoned.2 Community discussion around that case becomes polarised, with heated defence and criticism of his character and patient handling.2 We have also seen a prospective patient say the video consultation felt like a sales pitch, which made them sceptical.16 Some patients note inconsistent charges for similar graft counts, with one person feeling cheated, suggesting opacity around pricing communication.17

Pricing looks structured but not rigid. Reports describe either a base-plus-per-graft model or a tiered per-graft rate, with variation across time and patients.109181117 Several posts cite £4,000 for the first 1,000 grafts, then £3 per graft, for example 2,000 grafts at £7,000.918 Another report from late 2023 cites £4 per graft for the first 1,000 and £3 thereafter, effectively the same economics.10 Some recall earlier pricing closer to £3 per graft, implying fees have risen.9 A 2023 patient with 2,380 to 2,465 grafts reports paying about £6,000, while another paid £6,400 for under 2,000 grafts around the same time and felt cheated when learning of the lower cost for a larger count.617 Another patient paid £7,000 for roughly 2,000 grafts, said they benefited from 2023 prices, and noted he did not charge when the final grafts exceeded the quote, adding that he tends to quote on the lower side.11 One comment claims that by 2024 his price rose to about £4 per graft, though there is no clinic confirmation in these posts.11 We do not see detailed inclusions listed, but some patients mention extra small refinements or unplanned additional grafts were not billed separately.711

Key risks include the possibility of very poor growth and asymmetric cosmetic outcomes. We have seen a report of pretty much no growth, sparse coverage, and one side of the hairline not growing at all, despite being promised world class results.2 The same patient describes substantial difficulty securing adequate follow-up and feels Mittal avoided meeting properly after the failure, which suggests a risk of weak remediation if things go wrong.2 We have also read criticism of what is perceived as a tendency toward wonky, asymmetrical hairlines in some cases, with the failure cited as reinforcement.2 Community debate includes accusations that some highly positive commentary may be coming from very invested third parties, which could distort sentiment.2 Pricing inconsistency introduces a financial risk if expectations are not set clearly upfront.17 A prospective patient describing his consultation as a sales pitch highlights the chance that some interactions feel commercial rather than clinical.16 As with all FUE, risks like low density or suboptimal design apply, but in this set the standout issues are the single reported near-total failure, asymmetry concerns, and uncertainty about how reliably complications are owned and managed.2

Who might consider Mittal? Patients who want to stay in the UK, value direct surgeon involvement, and are comfortable with a doctor still building a track record but with multiple strong, natural-looking case reports.76138 He may suit those seeking conservative or age-appropriate hairlines, who are open to medical therapy like finasteride when advised, and who can attend in-person follow-ups in London.846 Prospective patients should scrutinise hairline symmetry and long-term planning, and pin down graft numbers, the pricing structure, and what happens if growth is poor.217 Those who are highly risk averse, have limited donor, or cannot tolerate a major aesthetic miss with uncertain remediation should be cautious, given the reported near-complete failure and follow-up concerns.2 People sensitive to hard-sell dynamics or who want a long, widely documented track record may prefer more established names, even at higher cost.163